Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2004 Jun 9;131(2):296–307. doi: 10.1016/0042-6822(83)90498-1

Antigenic relationships of murine coronaviruses: Analysis using monoclonal antibodies to JHM (MHV-4) virus

John O Fleming 1,1, Stephen A Stohlman 1, Richard C Harmon 1,2, Michael McLai 1, Jeffrey A Frelinger 1,3, Leslie P Weiner 1
PMCID: PMC7131482  PMID: 6318433

Abstract

Monoclonal antibodies were produced to JHMV-DL, a neurotropic member of the mouse hepatitis virus (MHV) or murine coronavirus group. Of 23 antibodies isolated, 10 were specific for the major envelope glycoprotein, gp180/90, 10 for the nucleocapsid protein, pp60, and 3 for the minor envelope glycoprotein, gp25. Eleven different MHV isolates were used in antibody binding assays to study antigenic relationships among the viruses. Each MHV isolate tested had a unique pattern of antibody binding, indicating that each is a distinct strain. Conservation of JHMV-DL antigenic determinants varied among the three proteins, with pp60 showing intermediate conservation, gp180/90 little conservation, and gp25 marked conservation in the different MHV strains. Monoclonal antibodies to pp60 proved most useful in delineating antigenic relationships among MHV strains. These antigenic groups correlated with pathogenic types, indicating that pp60 may be one of the gene products which mediates the distinct disease patterns manifested by different murine coronaviruses.

References

  1. Bailey O.T., Pappenheimer A.M., Cheever F.S., Daniels J.B. A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin. J. Exp. Med. 1949;90:195–212. doi: 10.1084/jem.90.3.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bond C.W., Leibowitz J.L., Robb J.A. Pathogenic murine coronaviruses: II, Characterization of virus-specific proteins of coronavirus JHMV and A59V. Virology. 1979;94:371–384. doi: 10.1016/0042-6822(79)90468-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cheley S., Morris V.L., Cupples M.J., Anderson R. RNA and polypeptide homology among murine coronaviruses. Virology. 1981;115:310–321. doi: 10.1016/0042-6822(81)90113-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Childs J.C., Stohlman S.A., Kingsford L., Russell R. Antigenic relationships of murine coronaviruses. Arch. Virol. 1983 doi: 10.1007/BF01310860. in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Collins A.R., Knobler R.L., Powell H., Buchmeier M.J. Monoclonal antibodies to marine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology. 1982;119:358–371. doi: 10.1016/0042-6822(82)90095-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Doel T.R., Brown F. Tryptic peptide analysis of the structural proteins of vesicular stomatitis virus. J. Gen. Virol. 1978;38:351–361. doi: 10.1099/0022-1317-38-2-351. [DOI] [PubMed] [Google Scholar]
  7. Fleming J.O., Ting J.Y.P., Stohlman S.A., Weiner L.P. Improvements in obtaining and characterizing mouse cerebrospinal fluid: application to mouse hepatitis virus induced encephalomyelitis. J. Neuroimmunol. 1983;4:129–140. doi: 10.1016/0165-5728(83)90017-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fields B.N., Greene M.I. Genetic and molecular mechanisms of viral pathogenesis: Implications for prevention and treatment. Nature (London) 1982;300:19–23. doi: 10.1038/300019a0. [DOI] [PubMed] [Google Scholar]
  9. Gerhard W., Yewdell J., Frankel M.E., Webster R. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature (London) 1981;290:713–717. doi: 10.1038/290713a0. [DOI] [PubMed] [Google Scholar]
  10. Gledhill A.W., Niven J.S.F. Latent virus as exemplified by mouse hepatitis virus (MHV) Vel. Rev. Annot. 1955;1:82–90. [Google Scholar]
  11. Harmon R.C., Shigekawa B., Stein N.M., Frelinger J.A. Problems associated with determining the specificity of monoclonal antibodies to major histocompatibility complex antigens. In: Mitchell M.S., Oettgen H.F., editors. Hybridomas in Cancer Diagnosis and Treatment. Raven Press; New York: 1982. pp. 21–30. [Google Scholar]
  12. Hierholzer J.C., Broderson J.R., Murphy F.A. New strain of mouse hepatitis virus as the cause of lethal enteritis in infant mice. Infect. Immun. 1979;24:508–522. doi: 10.1128/iai.24.2.508-522.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Holland J., Spindler K., Horodyski F., Grabau E., Nichol S., VandePol S. Rapid evolution of RNA genomes. Science. 1982;215:1577–1585. doi: 10.1126/science.7041255. [DOI] [PubMed] [Google Scholar]
  14. Holmes K.V., Doller E.W., Behnke J.N. Analysis of the functions of coronavirus glycoproteins by differential inhibition of synthesis with tunicamycin. In: ter Meulen V., Siddel S., Wege H., editors. Biochemistry and Biology of Coronaviruses. Plenum; New York: 1982. pp. 133–142. [DOI] [PubMed] [Google Scholar]
  15. Ishida T., Taguchi F., Lee Y.-S., Yamada A., Tamura T., Fujiwara K. Isolation of mouse hepatitis virus from infant mice with fatal diarrhea. Lab Anim. Sci. 1978;28:269–276. [PubMed] [Google Scholar]
  16. Ishida T., Tamura T., Ueda K., Fujiwara K. Hepatosplenic myelosis in naturally occurring mouse hepatitis infection in the nude mouse. Japan J. Vet. Sci. 1978;40:739–743. doi: 10.1292/jvms1939.40.739. [DOI] [PubMed] [Google Scholar]
  17. Kessler S.W. Use of protein A-bearing staphylococci for the immunoprecipitation and isolation of antigens from cells. Methods Enzymol. 1981;73:442–459. doi: 10.1016/0076-6879(81)73084-2. [DOI] [PubMed] [Google Scholar]
  18. Knobler R.L., Lampert P.W., Oldstone M.B.A. Virus persistence and recurring demyelinatinn produced by a temperature-sensitive mutant of MHV-4. Nature (London) 1982;298:279–283. doi: 10.1038/298279a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (London) 1975;256:495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  20. Lai M.M.C., Stohlman S.A. Comparative analysis of RNA genomes of mouse hepatitis viruses. J. Virol. 1981;38:661–670. doi: 10.1128/jvi.38.2.661-670.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lai M.M.C., Brayton P.R., Armen R.C., Patton C.D., Pugh C., Stohlman S.A. Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3. J. Virol. 1981;39:823–834. doi: 10.1128/jvi.39.3.823-834.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Laver W.G., Downie J.C. Influenza virus recombination. I. Matrix protein markers and segregation during mixed infections. Virology. 1976;70:105–117. doi: 10.1016/0042-6822(76)90240-3. [DOI] [PubMed] [Google Scholar]
  23. Littlefield J.W. Selection of hybrids from matings of fibroblasts in vitro and their presumed recombinants. Science. 1964;145:709–710. doi: 10.1126/science.145.3633.709. [DOI] [PubMed] [Google Scholar]
  24. Massalski A., Coulter-Mackie M., Knobler R.L., Buchmeier M.J., Dales S. In vitro and in vivo models of demyelinating diseases: V, Comparison of the assembly of mouse hepatitis virus, strain JHM, in two murine cell lines. Intervirology. 1982;18:135–146. doi: 10.1159/000149316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. McMillan M., Frelinger J.A., Jones P.P., Murphy D.B., McDevitt H.O., Hood L. Structure of murine la antigens: two-dimensional electrophoretic analysis and high-pressure liquid chromatography tryptic peptide maps of products of the I-A and I-E subregions and of an associated invariant polypeptide. J. Exp. Med. 1981;153:936–950. doi: 10.1084/jem.153.4.936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Niman H.L., Elder J.H. Structural analysis of Rauscher virus gp70 using monoclonal antibodies: sites of antigenicity and p15(E) linkage. Virology. 1982;123:187–205. doi: 10.1016/0042-6822(82)90305-1. [DOI] [PubMed] [Google Scholar]
  27. Nottay B.K., Kew O.M., Hatch M.H., Heyward J.T., Obijeski J.F. Molecular variation of type I vaccine-related and wild polioviruses during replication in humans. Virology. 1981;108:405–423. doi: 10.1016/0042-6822(81)90448-7. [DOI] [PubMed] [Google Scholar]
  28. Robb J.A., Bond C.W., Leibowitz J.L. Pathogenic murine coronaviruses: III, Biological and biochemical characterization of temperature sensitive mutants of JHMV. Virology. 1979;94:385–399. doi: 10.1016/0042-6822(79)90469-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rott R. Molecular basis of infectivity and pathogenicity of myxovirus: Brief review. Arch. Virol. 1979;59:285–298. doi: 10.1007/BF01317469. [DOI] [PubMed] [Google Scholar]
  30. Rowe W.P., Hartley J.W., Capps W.I. Vol. 112. 1963. Mouse hepatitis virus infection as a highly contagious, prevalent, enteric infection of mice; pp. 161–165. (Proc. Soc. Exp. Med. Biol.). [DOI] [PubMed] [Google Scholar]
  31. Stohlman S.A., Weiner L.P. Stability of neurotropic mouse hepatitis virus (JHM stain) during chronic infection of neuroblastoma cells. Arch. Virol. 1978;57:53–61. doi: 10.1007/BF01315637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Stohlman S.A., Weiner L.P. Chronic central nervous system demyelinatinn in mice after JHM virus infection. Neurology. 1981;31:38–44. doi: 10.1212/wnl.31.1.38. [DOI] [PubMed] [Google Scholar]
  33. Stohlman S.A., Brayton P.R., Fleming J.O., Weiner L.P., Lai M.M.C. Murine coronaviruses: isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. J. Gen. Virol. 1982;63:265–275. doi: 10.1099/0022-1317-63-2-265. [DOI] [PubMed] [Google Scholar]
  34. Sturman L.S. The structure and behavior of coronavirus A59 glycoproteins. In: ter Meulen V., Siddell S., Wege H., editors. Biochemistry and Biology of Coronaviruses. Plenum; New York: 1982. pp. 1–17. [Google Scholar]
  35. Sturman L.S., Holmes K.V. Academic Press; New York: 1983. The Molecular Biology of Coronaviruses. (in press) [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. ter Meulen V., Siddell S., Wege H., editors. Biochemistry and Biology of Caronaviruses. Plenum; New York: 1982. [Google Scholar]
  37. Wege H., Stephenson J.R., Koga M., Wege H., ter Meulen V. Genetic variation of neurotropic and non-neurotropic murine corona-viruses. J. Gen. Virol. 1981;54:67–74. doi: 10.1099/0022-1317-54-1-67. [DOI] [PubMed] [Google Scholar]
  38. Wege H., Siddell S., ter Meulen V. The biology and pathogenesis of coronavirus. Curr. Top. Micro. Biol. Immunol. 1982;99:165–200. doi: 10.1007/978-3-642-68528-6_5. [DOI] [PubMed] [Google Scholar]
  39. Weiner L.P. Pathogenesis of demyelination induced by a mouse hepatitis virus (JHM virus) Arch. Neural. 1973;28:298–303. doi: 10.1001/archneur.1973.00490230034003. [DOI] [PubMed] [Google Scholar]
  40. Virelizier J.L., Dayan A.D., Allison A.C. Neuropathological effects of persistent infection of mice by mouse hepatitis virus. Infect. Immun. 1975;12:1127–1140. doi: 10.1128/iai.12.5.1127-1140.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Virology are provided here courtesy of Elsevier

RESOURCES